Wave Life Sciences (WVE) Capital Leases (2015 - 2016)
Wave Life Sciences (WVE) posted Capital Leases of $16000.0 for Q4 2016, down 48.39% on a QoQ basis from $31000.0 in Q3 2016, and down 79.49% year-over-year from $78000.0 in Q1 2016.
Wave Life Sciences (WVE) Capital Leases (2015 - 2016) Analysis & Trends
Wave Life Sciences' Capital Leases history runs 2 years deep, the most recent figure standing at $16000.0 for Q4 2016.
- Quarterly Capital Leases fell 79.49% year-over-year to $16000.0 in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $16000.0 (down 79.49% YoY) and the FY2016 annual result came in at $16000.0, down 79.49% from the prior year.
- Capital Leases was $16000.0 for Q4 2016 at Wave Life Sciences, down from $31000.0 in the prior quarter.
- Across five years, Capital Leases topped out at $94000.0 in Q3 2015 and bottomed at $16000.0 in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 16,000.00 |
| Sep 30, 2016 | 31,000.00 |
| Jun 30, 2016 | 47,000.00 |
| Mar 31, 2016 | 62,000.00 |
| Dec 31, 2015 | 78,000.00 |
| Sep 30, 2015 | 94,000.00 |